Last reviewed · How we verify
NCT06763263
Effect of Superhero Clothing and Figure on Hospital Adjustment in Children During Hospitalization
NA trial testing Experimental in Hospitalization in Children in 62 participants. Participants enrolled and being followed up; not accepting new ones.
30 March 2025
Quick facts
| Lead sponsor | Nisa Meriç Turan |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 62 |
| Start date | 30 December 2024 |
| Primary completion | 30 March 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Experimental — full drug profile →
- Control
Conditions studied
- Hospitalization in Children — all drugs for Hospitalization in Children →
Sponsor
Nisa Meriç Turan
Who can join
Adults 24 Months to 36 Months, any sex, with Hospitalization in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Healthcare professionals and administrators who serve children are aware of the role of play in children's lives and with this awareness, they design playrooms and areas for children in hospitals. Nurses who consider play as an important atraumatic care approach that supports the child's development, reduces stress and anxiety, and thus contributes to the improvement of hospital compliance have conducted some studies on this subject. Sarman (2022) found in his study that animal-assisted treatment with aquarium fish in the hospital for children aged 8-10 was effective in reducing children's fear and anxiety, strengthening positive emotions, ensuring that the hospital environment was accepted as safe, reducing the feeling of loneliness and facilitating adaptation to the hospital. In another study, play and art therapy was applied to hospitalized children between the ages of 2 and 4, and it was determined that play therapy was more effective in reducing children's anxiety than art therapy and the control group. In their study evaluating the effect of the "hospital friend, Yarencik" initiative on the hospital adaptation of children aged 1-3, Özcan and Güdücü Tüfekci (2022) found that the hospital adaptation of the intervention group after the application was significantly higher than the control group. Although the above studies show that studies using developmentally appropriate and attractive methods to increase the compliance of young children to hospitalization are effective, the number of methods and studies tested is limited. Finding the best method to increase the compliance of young children to hospital and providing evidence that will form the basis for the development and updating of guides or guides is an important requirement.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06763263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Experimental
Trials testing the same drug.
- NCT07105943 — Manipulating Exercise Intensity and Affective Responses for Cardiac Rehabilitation Program Acute Coronary Syndrome Patie · NA · not yet recruiting
- NCT07471945 — Individualized Nursing Care and Frailty Outcomes in Cardiac Surgery · NA · not yet recruiting
- NCT07368881 — Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based Incentives · NA · not yet recruiting
- NCT07300358 — Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System · NA · not yet recruiting
- NCT07222774 — Strengthening Intentions · NA · active not recruiting
Other recruiting trials for Hospitalization in Children
Currently open trials in the same condition.
- NCT07217444 — Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06763263 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nisa Meriç Turan
- Last refreshed: 17 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06763263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing